Skip to main content
. Author manuscript; available in PMC: 2020 May 18.
Published in final edited form as: J Autoimmun. 2017 May 22;82:74–84. doi: 10.1016/j.jaut.2017.05.006

Fig. 4. MiR-146a deficiency leads to increased proliferation of synovial fibroblasts.

Fig. 4.

A, In vitro proliferation of wt and miR-146a−/− synovial fibroblasts, measured by 3[H] thymidine incorporation (data shown are representative of 3 independent experiments). B, Hematoxylin and eosin staining from histological sections of wt and miR-146a−/− synovial fibroblasts cultured in micromasses (bars 500 μm, magnification x 5). C, Quantification of Ki-67+ synovial fibroblast cells among total synovial lining cells, from immunohistochemically stained sections of micromasses from wt (n = 7) and miR-146a−/− (n = 7) mice using anti Ki-67 antibody. D, Expression level of TRAF6 in synovial fibroblasts from wt (n = 9) and miR-146a−/− (n = 10) animals was analyzed using quantitative real time PCR. E and F, Synovial fibroblasts from wt or miR-146a deficient animals were transfected with either control (Ctrl) or TRAF6 siRNA, proliferation analysis was performed using 3[H]thymidine incorporation (data shown are mean values of 2 independent experiments). *p < 0,05, **p < 0,01, ***p < 0,001 Results are shown as mean ± SEM.